| In vivo CRISPR base editing of PCSK9 durably lowers cholesterol in primates K Musunuru, AC Chadwick, T Mizoguchi, SP Garcia, JE DeNizio, ... Nature 593 (7859), 429-434, 2021 | 568 | 2021 |
| T2 relaxation induced by clusters of superparamagnetic nanoparticles: Monte Carlo simulations Y Matsumoto, A Jasanoff Magnetic resonance imaging 26 (7), 994-998, 2008 | 173 | 2008 |
| High-performance ferrite nanoparticles through nonaqueous redox phase tuning R Chen, MG Christiansen, A Sourakov, A Mohr, Y Matsumoto, S Okada, ... Nano letters 16 (2), 1345-1351, 2016 | 115 | 2016 |
| Engineering intracellular biomineralization and biosensing by a magnetic protein Y Matsumoto, R Chen, P Anikeeva, A Jasanoff Nature communications 6 (1), 8721, 2015 | 76 | 2015 |
| GalNAc-Lipid nanoparticles enable non-LDLR dependent hepatic delivery of a CRISPR base editing therapy LN Kasiewicz, S Biswas, A Beach, H Ren, C Dutta, AM Mazzola, E Rohde, ... Nature Communications 14 (1), 2776, 2023 | 49 | 2023 |
| Quantification of isomers from a mixture of twelve heparin and heparan sulfate disaccharides using tandem mass spectrometry JR Behr, Y Matsumoto, FM White, R Sasisekharan Rapid Communications in Mass Spectrometry: An International Journal Devoted …, 2005 | 47 | 2005 |
| Metalloprotein-based MRI probes Y Matsumoto, A Jasanoff FEBS letters 587 (8), 1021-1029, 2013 | 37 | 2013 |
| An investigational in vivo base editing medicine targeting ANGPTL3, VERVE-201, achieves precise and durable liver editing in nonclinical studies R Lee, A Mazzola, J Denizio, T Mizoguchi, V Clendaniel, R Garrity, N Cox, ... Atherosclerosis 395, 2024 | | 2024 |
| Cysteine Sulfinic Acid Decarboxylase Regulation: A Role for FXR and SHP in Murine Hepatic Taurine Metabolism TA Kerr, Y Matsumoto, H Matsumoto, Y Xie, LL Hirschberger, ... Hepatology research: the official journal of the Japan Society of Hepatology …, 2014 | | 2014 |
| Engineering genetically-encodable MRI contrast agents for in vivo imaging Y Matsumoto Massachusetts Institute of Technology, 2014 | | 2014 |
| 829 Cysteine Sulfinic Acid Decarboxylase Regulation by Bile Acids: A Role for FXR and SHP in Hepatic Taurine Metabolism TA Kerr, Y Matsumoto, H Matsumoto, Y Xie, S Anakk, S Kennedy, ... Gastroenterology 5 (142), S-930, 2012 | | 2012 |
| Joshi, BP, 31 D Balasubramanian, A Barbosa, T Berthoud, R Bhatnagar, S Biswas, ... | | |
| Modeling of Thin Wires in a Lossy Medium for FDTD Simulations........... Y. Baba, N. Nagaoka, and A. Ametani 54 Human Exposure to EM Fields Generalized Transmission-Line Model … RL Chen, J Chen, TH Hubing, W Shi, P Baccarelli, P Burghignoli, ... | | |
